Pharmafile Logo
Pharmafocus logo
Advanced Search

2010 financials

Showing 15 posts of 20 posts found.

Novartis posts strong Q3 results

October 21, 2010
Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales

Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …

News
Swiss pharma company Roche

Roche revenue depressed by plummeting Tamiflu sales

October 15, 2010
Sales and Marketing 2010 financials, Q3, Roche

Roche suffered a 3% drop in group revenue in the third quarter as sales of its Tamiflu plummeted by 90 …

News
Boehringer building at night

Generic competition hits Boehringer sales

August 9, 2010
Sales and Marketing 2010 financials, Boehringer, Q2

Boehringer Ingelheim’s sales fell 5% in the first half of 2010, depressed by generic competition and then further dragged down …

News

Victoza lifts Novo Nordisk

August 9, 2010
Sales and Marketing 2010 financials, Novo Nordisk, Q2

Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …

News

Wyeth acquisition boosts Pfizer results

August 4, 2010
Sales and Marketing 2010 financials, Pfizer, Q2

Pfizer’s second quarter results received a huge boost from the company’s multi-billion dollar acquisition of Wyeth last October. Sales of …

News

New products help lift UCB

August 3, 2010
Sales and Marketing 2010 financials, Q2, UCB

UCB’s newer products showed impressive growth in the first six months of this year, helping keep the Belgium-based biopharma firm’s …

News

Merck merger costs halve profits

August 2, 2010
Sales and Marketing 2010 financials, Merck & Co, Q2

Shares in Merck & Co fell as costs relating to the merger with Schering-Plough put a huge dent in second …

News

FDA recommends Brilinta

July 30, 2010
Sales and Marketing 2010 financials, AstraZeneca, Brillinta, Q2

FDA advisors have voted in favour of AstraZeneca’s antiplatelet drug Brilinta, which is currently seeking a licence for the reduction …

News

Sanofi’s blockbusters take a hit

July 29, 2010
Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis

Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …

News

Lonza boosts profit despite contract manufacturing downturn

July 23, 2010
Manufacturing and Production 2010 financials, Lonza, Q2

Switzerland’s Lonza posted a healthy increase in profits in the first half of 2010, topping analysts’ expectations, although sales dipped …

News

Roche sees slow sales amid market pressures

July 22, 2010
Sales and Marketing 2010 financials, Q2, Roche

Roche has posted average first half year results with pharma sales that showed only low single digit growth. They showed …

News

Abbott boosted by Solvay integration

July 22, 2010
Sales and Marketing 2010 financials, Abbott, Q2, Solvay

Abbott has posted a set of strong sales for the second quarter, buoyed by the integration of Solvay Pharmaceuticals and …

News
Genzyme

Manufacturing woes hit Genzyme results

July 22, 2010
2010 financials, Genzyme, Q2

Genzyme has posted a decrease in sales for the second quarter as its manufacturing woes continue. The US-based biopharma company …

News

Legal costs dent GlaxoSmithKline’s Q2

July 22, 2010
Medical Communications, Sales and Marketing 2010 financials, GlaxoSmithKline, Q2

GSK has reported a loss for its second quarter due to litigation costs related to Avandia and other problems. In …

News

J&J post modest second quarter increase

July 21, 2010
Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026